SB-224289
SB-224289 is a chemical compound that acts as a selective antagonist for the 5-HT1B receptor, a subtype of the serotonin receptor family. This compound has been utilized in scientific research to explore the role of 5-HT1B receptors in various physiological and pathological processes.
Chemical Structure and Properties
SB-224289 is characterized by its specific binding affinity to the 5-HT1B receptor, which distinguishes it from other serotonin receptor subtypes. The molecular formula of SB-224289 is C19H20N4O, and it has a molecular weight of 320.39 g/mol. The compound is typically synthesized in laboratory settings for research purposes.
Mechanism of Action
As a selective antagonist, SB-224289 binds to the 5-HT1B receptor and inhibits its activity. The 5-HT1B receptor is a G protein-coupled receptor (GPCR) that is involved in the modulation of neurotransmitter release, particularly serotonin. By blocking this receptor, SB-224289 can alter serotonin signaling pathways, which has implications for understanding mood regulation, anxiety, and other neuropsychiatric conditions.
Research Applications
SB-224289 has been used extensively in preclinical studies to investigate the role of 5-HT1B receptors in the central nervous system. Some key areas of research include:
- Mood Disorders: Studies have explored how SB-224289 affects behaviors related to depression and anxiety, providing insights into potential therapeutic targets for these conditions.
- Migraine: The 5-HT1B receptor is implicated in the pathophysiology of migraines, and SB-224289 has been used to study its role in migraine models.
- Substance Use Disorders: Research has examined how SB-224289 influences the rewarding effects of drugs of abuse, contributing to the understanding of addiction mechanisms.
Pharmacokinetics
The pharmacokinetic profile of SB-224289 includes its absorption, distribution, metabolism, and excretion characteristics. These properties are crucial for determining the compound's efficacy and safety in experimental settings. However, detailed pharmacokinetic data specific to SB-224289 may vary depending on the study design and model organism used.
Safety and Toxicology
As with many research chemicals, the safety and toxicological profile of SB-224289 is primarily assessed in controlled laboratory environments. Researchers must adhere to safety guidelines and regulations when handling and administering this compound.
Also see
- 5-HT1B receptor
- Serotonin receptor
- Antagonist (pharmacology)
- Neurotransmitter
- G protein-coupled receptor
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD